Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Fed Cuts Rates, Causing Gold to See-Saw

Yesterday, that was already the third time this year when the Fed cut interest rates. In response, the price of gold erased earlier losses. That sounds a bit fishy. What is going on? Fed Lowers Interest Rates by 25 Basis Points Yesterday, the FOMC published the monet...
Arkadiusz Sieron | October 31, 2019 |

Fed Cuts and Gold Drops. Again

History may not repeat itself to the letter but it certainly rhymes. That’s what the Fed watchers would say now. The Fed cut the interest rates for the second time this year and the price of gold declined again. What is going on? Fed Trims Interest Rates by ...
Arkadiusz Sieron | September 19, 2019 |

Benefactor of Interest Rate Cuts

Last week for the first time since 2008, the Federal Reserve cut interest rates. But was this rate cut needed? The Fed has been trying to force feed consumers who contribute about 70% to GDP to keep borrowing and spending. The plan has been working thus far as the economic e...
Dr. Kal Kotecha | August 7, 2019 |

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer...

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer for Investigative Antisense Therapy, Shares Up 30% Akcea Therapeutics' shares are trading 30% higher today on news that it has entered into a worldwide exclusive licensing agreement with Pfizer for AKCEA-ANG...
Streetwise Reports | October 8, 2019 |

Protalix Shares Trade up 70% Upon Release of Phase 3 Fabry Disease Data

Shares of Protalix Biotherapeutics skyrocketed today on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease. Earl...
Streetwise Reports | October 18, 2019 |

Akero Therapeutics Shares Rise on Positive Data from Phase 2a NASH Study

Akero Therapeutics shares traded 28% higher and established a new 52-week high after the company reported that it recorded positive histological data across all Efruxifermin dosage groups in its Phase 2a BALANCED Study in NASH patients. Clinical-stage biotechnology...
Streetwise Reports | July 2, 2020 |

Crude Cuts Get Another Saudi Boost as Oil Demand Begins to Show Signs of Life

Saudi Arabia enhanced their commitment to OPEC+ supply cuts as the Kingdom said they'd shut production of additional 1 million barrels of crude oil per day next month. Most of the OPEC+ countries have already come close to compliance with the deal that took effect this mo...
Streetwise Reports | May 22, 2020 |

Market Action Suggests Downside in Precious Metals

At present, there could be a number of positive developments for precious metals. Last Friday, the US Dollar cracked lower and could be at risk of lower levels into year end. Days earlier the Federal Reserve announced new “QE-like” measures just a...
Jordan Roy-Byrne, CMT | October 15, 2019 |

Oil Price Fundamental Daily Forecast – ...

Oil Price Fundamental Daily Forecast – Supply/Demand Picture Rosy; Low Volume Biggest Concern for Traders Speculative buyers have been driving prices higher for weeks on the hope of supply cuts and a trade deal. Low pre-holiday volume could cause these buyers to curtail...
FX Empire | December 20, 2019 |

Biopharma Reports Consistent 'Phase 2 Liver Fat (NASH and NAFLD) Results'

The new data are reviewed and updates are provided on Can-Fite BioPharma's other clinical studies, including one for COVID-19, in this Dawson James research report. In an April 20 research note, Dawson James analyst Jason Kolbert wrote that results from Can...
Streetwise Reports | April 23, 2020 |
1 2 3 4 5 6 7 8 9 10 ...